Moderna, Inc. (MRNA) revenue & profit
Moderna, Inc. (MRNA): revenue $1.9B, net income -$2.8B in 2025; latest quarter +2.1% year over year. From SEC filings.
$1.9BRevenue 2025
TickerMRNA (Nasdaq)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$1.9B
Net income 2025-$2.8B
Net margin-145.2%
Annual revenue growth-39.9%
Latest quarter (2026 Q2) · Revenue$145M
vs. same quarter last year+2.1%
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $19.3B | $8.4B | |
| 2023 | $6.8B | -$4.7B | |
| 2024 | $3.2B | -$3.6B | |
| 2025 | $1.9B | -$2.8B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.